Ocugen (OCGN) Cash & Current Investments (2014 - 2025)
Ocugen (OCGN) posted Cash & Current Investments of $37.8 million for Q1 2025, up 140.81% on a QoQ basis from $15.7 million in Q2 2024, and up 43.32% year-over-year from $26.4 million in Q1 2024.
Ocugen (OCGN) Cash & Current Investments (2014 - 2025) Analysis & Trends
Ocugen's Cash & Current Investments history runs 12 years deep, the most recent figure standing at $37.8 million for Q1 2025.
- Quarterly Cash & Current Investments rose 43.32% year-over-year to $37.8 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $37.8 million (up 43.32% YoY) and the FY2023 annual result came in at $39.5 million, down 56.6% from the prior year.
- Cash & Current Investments was $37.8 million for Q1 2025 at Ocugen, up from $15.7 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $129.8 million in Q1 2022 and bottomed at $15.7 million in Q2 2024.
- A 5-year average of $75.7 million and a median of $76.7 million in 2023 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2021 — Cash & Current Investments jumped 1459.04% — and 2024, when it slumped 77.76%.
- Ocugen's Cash & Current Investments stood at $95.0 million in 2021, then fell by 4.24% to $90.9 million in 2022, then plunged by 56.6% to $39.5 million in 2023, then slumped by 60.22% to $15.7 million in 2024, then jumped by 140.81% to $37.8 million in 2025.
- Business Quant data shows OCGN's Cash & Current Investments at $37.8 million in Q1 2025, $15.7 million in Q2 2024, and $26.4 million in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Ocugen | 415.98 Mn | 415.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 37.80 Mn |
| Jun 30, 2024 | 15.70 Mn |
| Mar 31, 2024 | 26.38 Mn |
| Dec 31, 2023 | 39.46 Mn |
| Sep 30, 2023 | 53.48 Mn |
| Jun 30, 2023 | 70.58 Mn |
| Mar 31, 2023 | 76.72 Mn |
| Dec 31, 2022 | 90.93 Mn |
| Sep 30, 2022 | 101.60 Mn |
| Jun 30, 2022 | 115.01 Mn |
| Mar 31, 2022 | 129.77 Mn |
| Dec 31, 2021 | 94.96 Mn |
| Sep 30, 2021 | 112.34 Mn |
| Jun 30, 2021 | 120.63 Mn |
| Mar 31, 2021 | 49.78 Mn |
| Dec 31, 2020 | 24.04 Mn |
| Sep 30, 2020 | 19.11 Mn |
| Jun 30, 2020 | 14.97 Mn |
| Mar 31, 2020 | 3.19 Mn |
| Dec 31, 2019 | 7.44 Mn |